Titan Pharmaceuticals Inc financial data

Symbol
TTNP on Nasdaq, TTNPW on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
400 Oyster Point Blvd, Suite 505, San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 438 % +138%
Quick Ratio 11.2 % +24%
Debt-to-equity 28.8 % -72%
Return On Equity -99.9 % +72.5%
Return On Assets -77.6 % +56.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 914K shares -93.9%
Common Stock, Shares, Outstanding 914K shares -93.9%
Entity Public Float 7.3M USD -71.5%
Weighted Average Number of Shares Outstanding, Basic 853K shares +13.6%
Weighted Average Number of Shares Outstanding, Diluted 853K shares +13.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.91M USD -59.8%
General and Administrative Expense 5.38M USD -9.57%
Costs and Expenses 2.47M USD -9.75%
Operating Income (Loss) -6.64M USD +29.3%
Nonoperating Income (Expense) 1.69M USD +3148%
Income Tax Expense (Benefit) 1K USD
Net Income (Loss) Attributable to Parent -4.95M USD +47%
Earnings Per Share, Basic -6.42 USD/shares +44.4%
Earnings Per Share, Diluted -6.42 USD/shares +62.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.16M USD +442%
Accounts Receivable, after Allowance for Credit Loss, Current 134K USD +1575%
Inventory, Net 0 USD -100%
Assets, Current 6.61M USD +270%
Property, Plant and Equipment, Net 3K USD -98.3%
Operating Lease, Right-of-Use Asset 32K USD -79.2%
Other Assets, Noncurrent 48K USD 0%
Assets 6.65M USD +207%
Accounts Payable, Current 371K USD -34.6%
Liabilities, Current 559K USD -77.2%
Operating Lease, Liability, Noncurrent 33K USD -79.1%
Liabilities 559K USD -77.5%
Retained Earnings (Accumulated Deficit) -393M USD -1.28%
Stockholders' Equity Attributable to Parent 6.09M USD
Liabilities and Equity 6.65M USD +207%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -613K USD +67.7%
Net Cash Provided by (Used in) Financing Activities 10M USD +101%
Net Cash Provided by (Used in) Investing Activities 732K USD
Common Stock, Shares Authorized 225M shares 0%
Common Stock, Shares, Issued 914K shares -93.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.16M USD +399%
Interest Paid, Excluding Capitalized Interest, Operating Activities 13K USD
Deferred Tax Assets, Valuation Allowance 65M USD -7.55%
Deferred Tax Assets, Gross 65M USD -7.58%
Operating Lease, Liability 33K USD -79.1%
Payments to Acquire Property, Plant, and Equipment 2K USD
Lessee, Operating Lease, Liability, to be Paid 33K USD -79.9%
Property, Plant and Equipment, Gross 711K USD -60.9%
Operating Lease, Liability, Current 33K USD -73.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 66K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 33K USD -66.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -88.9%
Deferred Tax Assets, Operating Loss Carryforwards 53.2M USD -8.07%
Preferred Stock, Shares Issued 950K shares
Preferred Stock, Shares Authorized 5M shares
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 399M USD +2.93%
Preferred Stock, Shares Outstanding 950K shares
Depreciation, Depletion and Amortization 2K USD -95.3%
Share-based Payment Arrangement, Expense 1.01M USD +6.97%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares